Celldex Therapeutics, Inc. Company Information

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Celldex Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

Name: Celldex Therapeutics, Inc.
Ticker: TCE2
Exchange: DB
Founded: 1983
Industry: Biotechnology
Sector: Pharmaceuticals & Biotech
Market Cap: US$1.792b
Listing Market Cap: US$1.712b
Shares Outstanding: 66.34m
Website: https://www.celldex.com

Number of Employees

Location

Celldex Therapeutics, Inc.
Perryville III Building
Suite 220
Hampton
New Jersey
08827
United States

Listings

Ticker	Exchange	Primary Security	Security Type	Country	Currency	Listed on
CLDX	NasdaqCM (Nasdaq Capital Market)	Yes	Common Stock with Par Value 0.001	US	USD	Mar 2008
TCE2	DB (Deutsche Boerse AG)	Yes	Common Stock with Par Value 0.001	DE	EUR	Mar 2008

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
Data	Last Updated (UTC time)
Company Analysis	2024/12/12 12:30
End of Day Share Price	2024/12/12 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.